Pragmatic Trial of Messaging to Providers About Treatment of Heart Failure

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT04514458
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Best practice alert for the notification of patient HFrEF and recommended evidence-based therapies (NO drugs are being administered in this trial) — OTHER
    Providers will receive a best practice alert for each of their eligible patients upon opening of the order entry screen in the patient's medical record. The alert will inform the provider to the presence of HFrEF and of the patient's current left ventricular ejection fraction and current evidence-based medications for HFrEF. It will also provide access to an order set with recommended evidence-based HFrEF therapies as well as a link to the best available guideline-recommended information regarding the treatment of heart failure.

Study Details

A randomized controlled trial to compare the efficacy of an electronic health record-based alert informing providers about evidence-based medications for HFrEF versus usual care (no alert) in outpatient clinics across a single health system.

Key Dates

Start date
Jan 25, 2021
Status verified
Jun 2025
Primary completion
Nov 20, 2021
Completion
Oct 20, 2022

Study Design

Enrollment
1,410 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: EHR-based alert
    Providers will receive a best practice alert for each of their eligible patients upon opening of the order entry screen in the patient's medical record. The alert will inform the provider to the presence of HFrEF and of the patient's current left ventricular ejection fraction and current evidence-based medications for HFrEF. It will also provide access to an order set with recommended evidence-based HFrEF therapies as well as a link to the best available guideline-recommended information regarding the treatment of heart failure.
  • No Intervention: Usual Care
    Providers will not receive an alert and will proceed with usual care.

Primary Outcome Measure

Percentage of Patients With Heart Failure With Reduced Ejection Fraction (HFrEF) With an Increase in Prescribed HFrEF Therapy [ Time Frame: Assessed from the date of randomization to 30 days post-randomization ]

Locations (1)

FacilityCityStateZIPSite coordinators
Yale New Haven Health System selected outpatient clinicsNew HavenConnecticut06510-

Find similar trials in New Haven, CT

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
Yale New Haven Health System selected outpatient clinics· New Haven, CT

Related Studies